![Yoshitsuga Shitaka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yoshitsuga Shitaka
President chez OCATA THERAPEUTICS INC
Postes actifs de Yoshitsuga Shitaka
Sociétés | Poste | Début | Fin |
---|---|---|---|
OCATA THERAPEUTICS INC | Directeur/Membre du Conseil | - | - |
Directeur Technique/Scientifique/R&D | - | - | |
President | - | - | |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Directeur Général | - | - |
Historique de carrière de Yoshitsuga Shitaka
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Astellas Institute for Regenerative Medicine
![]() Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
- Bourse
- Insiders
- Yoshitsuga Shitaka
- Expérience